Chemours finds material weaknesses after internal review (NYSE:CC)
JHVEPhoto Chemours (NYSE:CC) stock on Wednesday slid nearly 11% in extended trading, after the chemical manufacturer finally filed its twice-delayed annual report which showed a smaller loss for Q4 2023 and said its internal review had…
